Dementia and Geriatric Cognitive Disorders

Original Research Article

Association Study and Meta-Analysis of Polymorphisms, Methylation Profiles, and Peripheral mRNA Expression of the Serotonin Transporter Gene in Patients with Alzheimer's Disease

Yamazaki K. · Yoshino Y. · Mori T. · Okita M. · Yoshida T. · Mori Y. · Ozaki Y. · Sao T. · Iga J. · Ueno S.

Author affiliations

Department of Neuropsychiatry, Molecules and Function, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Japan

Keywords: Serotonin transporterAlzheimer’s diseasemRNAEpigeneticsApathyMeta-analysis

Related Articles for ""
Dement Geriatr Cogn Disord 2016;41:334-347
https://doi.org/10.1159/000447324

Log in to MyKarger to check if you already have access to this content.




Forgot your password
Sign up to MyKarger

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates

Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Research Article

Accepted: June 01, 2016
Published online: July 15, 2016
Issue release date: August 2016

Number of Print Pages: 14
Number of Figures: 6
Number of Tables: 4

ISSN: 1420-8008 (Print)
eISSN: 1421-9824 (Online)

For additional information: https://www.karger.com/DEM

Abstract

Background/Aim: The aim of this study was to elucidate the relationship between Alzheimer's disease (AD) and the serotonin transporter gene (SLC6A4). Methods: AD subjects (n = 43) and controls (n = 47) were recruited and evaluated. In leukocytes, we evaluated two polymorphisms in SLC6A4, the serotonin transporter length polymorphic region (5-HTT-LPR) and rs25531, as well as methylation rates of the SLC6A4 promoter region and the SLC6A4 mRNA expression level. We also performed a meta-analysis to examine the relationship between the frequency of the L allele and the risk of AD. Results: The distributions of 5-HTT-LPR and rs25531 polymorphisms in AD subjects were not different from those of controls. Although the methylation rates in AD subjects were not significantly different from those of controls, the expression level in AD subjects was significantly higher than in controls. Additionally, the expression level in AD subjects was significantly correlated with apathy. Meta-analysis revealed that the L/L genotype significantly reduced the risk of AD, but only in the Caucasian population. Conclusion: Higher SLC6A4 mRNA expression in leukocytes in AD was associated with apathy regardless of SLC6A4 genotypes and methylation rates of the promoter region. The L/L genotype may reduce the risk of AD in the Caucasian population.

© 2016 S. Karger AG, Basel



Related Articles:

References

  1. Jorm AF: Effects of cholinergic enhancement therapies on memory function in Alzheimer's disease: a meta-analysis of the literature. Aust NZ J Psychiatry 1986;20:237-240.
    External Resources
  2. Wilkinson DG, Francis PT, Schwam E, Payne-Parrish J: Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy. Drugs Aging 2004;21:453-478.
    External Resources
  3. Frazer A, Hensler JG: Molecular, cellular and medical aspects; in Siegel JS, Agranoff BW, Albers RW, Molinoff PB (eds): Basic Neurochemistry, ed 5. Philadelphia, Lippincott-Raven, 1994, pp 283-308.
  4. Hornung JP: The human raphe nuclei and the serotonergic system. J Chem Neuroanat 2003;26:331-343.
    External Resources
  5. Fujita M, Shimada S, Maeno H, Nishimura T, Tohyama M: Cellular localization of serotonin transporter mRNA in the rat brain. Neurosci Lett 1993;162:59-62.
    External Resources
  6. Heils A, Teufel A, Petri S, Stöber G, Riederer P, Bengel D, Lesch KP: Allelic variation of human serotonin transporter gene expression. J Neurochem 1996;66:2621-2624.
    External Resources
  7. Karg K, Burmeister M, Shedden K, Sen S: The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry 2011;68:444-454.
    External Resources
  8. Nakamura M, Ueno S, Sano A, Tanabe H: The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry 2000;5:32-38.
    External Resources
  9. Kraft JB, Slager SL, McGrath PJ, Hamilton SP: Sequence analysis of the serotonin transporter and associations with antidepressant response. Biol Psychiatry 2005;58:374-381.
    External Resources
  10. Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, Xu K, Arnold PD, Richter MA, Kennedy JL, Murphy DL, Goldman D: Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 2006;78:815-826.
    External Resources
  11. Ehli EA, Hu Y, Lengyel-Nelson T, Hudziak JJ, Davies GE: Identification and functional characterization of three novel alleles for the serotonin transporter-linked polymorphic region. Mol Psychiatry 2012;17:185-192.
    External Resources
  12. Seripa D, Iurescia S, Rinaldi M, Pilotto A, Paroni G, Bazzano S, Antonelli A, Gravina C, Urbano M, Padovani A, Pilotto A: The serotonin transporter gene-linked polymorphic region: identification and functional characterization of novel alleles. Eur Geriatr Med 2013;4:S100.
    External Resources
  13. Philibert R, Madan A, Andersen A, Cadoret R, Packer H, Sandhu H: Serotonin transporter mRNA levels are associated with the methylation of an upstream CpG island. Am J Med Genet B Neuropsychiatr Genet 2007;144B:101-105.
    External Resources
  14. Wankerl M, Miller R, Kirschbaum C, Hennig J, Stalder T, Alexander N: Effects of genetic and early environmental risk factors for depression on serotonin transporter expression and methylation profiles. Transl Psychiatry 2014;4:e402.
    External Resources
  15. Sukonick DL, Pollock BG, Sweet RA, Mulsant BH, Rosen J, Klunk WE, Kastango KB, DeKosky ST, Ferrell RE: The 5-HTTPR *S/*L polymorphism and aggressive behaviour in Alzheimer's disease. Arch Neurol 2001;58:1425-1428.
    External Resources
  16. Sweet RA, Pollock BG, Sukonick DL, Mulsant BH, Rosen J, Klunk WE, Kastango KB, DeKosky ST, Ferrell RE: The 5-HTTPR polymorphism confers liability to a combined phenotype of psychotic and aggressive behavior in Alzheimer disease. Int Psychogeriatr 2001;13:401-409.
    External Resources
  17. Borroni B, Grassi M, Agosti C, Archetti S, Costanzi C, Cornali C, Caltagirone C, Caimi L, Di Luca M, Padovani A: Cumulative effect of COMT and 5-HTTLPR polymorphisms and their interaction with disease severity and comorbidities on the risk of psychosis in Alzheimer disease. Am J Geriatr Psychiatry 2006;14:343-351.
    External Resources
  18. Pitchard AL, Pritchard CW, Bentham P, Lendon CL: Role of serotonin transporter polymorphisms in the behavioural and psychological symptoms in probable Alzheimer disease patients. Dement Geriatr Cogn Disord 2007;24:201-206.
    External Resources
  19. Quaranta D, Bizzarro A, Marra C, Vita MG, Seripa D, Pilotto A, Sebastiani V, Mecocci P, Masullo C: Psychotic symptoms in Alzheimer's disease and 5-HTTLPR polymorphism of the serotonin transporter gene: evidence for an association. J Alzheimers Dis 2009;16:173-180.
    External Resources
  20. Proitsi P, Lupton MK, Reeves SJ, Hamilton G, Archer N, Martin BM, Iyegbe C, Hollingworth P, Lawlor B, Gill M, Brayne C, Rubinsztein DC, Owen MJ, Williams J, Lovestone S, Powell JF: Association of serotonin and dopamine gene pathways with behavioral subphenotypes in dementia. Neurobiol Aging 2012;33:791-803.
    External Resources
  21. Li T, Holmes C, Sham PC, Vallada H, Birkett J, Kirov G, Lesch KP, Powell J, Lovestone S, Collier D: Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer's disease. Neuroreport 1997;8:683-686.
    External Resources
  22. Rocchi A, Micheli D, Ceravolo R, Manca ML, Tognoni G, Siciliano G, Murri L: Serotoninergic polymorphisms (5-HTTLPR and 5-HT2A): association studies with psychosis in Alzheimer disease. Genet Test 2003;7:309-314.
    External Resources
  23. Assal F, Alarcón M, Solomon EC, Masterman D, Geschwind DH, Cummings JL: Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease. Arch Neurol 2004;61:1249-1253.
    External Resources
  24. Ha TM, Cho DM, Park SW, Joo MJ, Lee BJ, Kong BG, Kim JM, Yoon JS, Kim YH: Evaluating associations between 5-HTTLPR polymorphism and Alzheimer's disease for Korean patients. Dement Geriatr Cogn Disord 2005;20:31-34.
    External Resources
  25. Micheli D, Bonvicini C, Rocchi A, Ceravolo R, Mancuso M, Tognoni G, Gennarelli M, Siciliano G, Murri L: No evidence for allelic association of serotonin 2A receptor and transporter gene polymorphisms with depression in Alzheimer disease. J Alzheimers Dis 2006;10:371-378.
    External Resources
  26. Ueki A, Ueno H, Sato N, Shinjo H, Morita Y: Serotonin transporter gene polymorphism and BPSD in mild Alzheimer's disease. J Alzheimers Dis 2007;12:245-253.
    External Resources
  27. Grünblatt E, Zehetmayer S, Bartl J, Löffler C, Wichart I, Rainer MK, Jungwirth S, Bauer P, Danielczyk W, Tragl KH, Riederer P, Fischer P: Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study. J Psychiatr Res 2009;43:298-308.
    External Resources
  28. Albani D, Prato F, Tettamanti M, Lovati C, Galimberti D, Restelli I, Mariani C, Quadri PL, Scarpini E, Lucca U, Forloni G.: The serotonin transporter promoter polymorphic region is not a risk factor for Alzheimer's disease related behavioral disturbances. J Alzheimers Dis 2009;18:125-130.
    External Resources
  29. Iga J, Ueno S, Yamauchi K, Motoki I, Tayoshi S, Ohta K, Song H, Morita K, Rokutan K, Ohmori T: Serotonin transporter mRNA expression in peripheral leukocytes of patients with major depression before and after treatment with paroxetine. Neurosci Lett 2005;389:12-16.
    External Resources
  30. Tsao CW, Lin YS, Chen CC, Bai CH, Wu SR: Cytokines and serotonin transporter in patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:899-905.
    External Resources
  31. Thomas AJ, Hendriksen M, Piggott M, Ferrier IN, Perry E, Ince P, O'Brien JT: A study of the serotonin transporter in the prefrontal cortex in late-life depression and Alzheimer's disease with and without depression. Neuropathol Appl Neurobiol 2006;32:296-303.
    External Resources
  32. Chen KH, Reese EA, Kim HW, Rapoport SI, Rao JS: Disturbed neurotransmitter transporter expression in Alzheimer's disease brain. J Alzheimers Dis 2011;26:755-766.
    External Resources
  33. Creese B, Ballard C, Jones E: Cognitive impairment in studies of 5HTTLPR and psychosis in Alzheimer's disease: a systematic review. Dement Geriatr Cogn Disord 2013;35:155-164.
    External Resources
  34. Watanabe SY, Iga J, Numata S, Umehara H, Nishi A, Kinoshita M, Inoshita M, Ohmori T: Polymorphism in the promoter of the gene for the serotonin transporter affects the age of onset of major depressive disorder in the Japanese population. J Affect Disord 2015;183:156-158.
    External Resources
  35. Ouchi Y, Yoshikawa E, Futatsubashi M, Yagi S, Ueki T, Nakamura K: Altered brain serotonin transporter and associated glucose metabolism in Alzheimer disease. J Nucl Med 2009;50:1260-1266.
    External Resources
  36. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH: The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:263-269.
    External Resources
  37. Folstein MF, Folstein SE, McHugh PR: ‘Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
    External Resources
  38. Morris JC: The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
    External Resources
  39. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314.
    External Resources
  40. De Luca V, Tharmalingam S, King N, Strauss J, Bulgin N, Kennedy JL: Association study of a novel functional polymorphism of the serotonin transporter gene in bipolar disorder and suicidal behavior. Psychopharmacology (Berl) 2005;182:128-131.
    External Resources
  41. De Luca V, Zai G, Tharmalingam S, de Bartolomeis A, Wong G, Kennedy JL: Association study between the novel functional polymorphism of the serotonin transporter gene and suicidal behavior in schizophrenia. Eur Neuropsychopharmacol 2006;6:268-271.
    External Resources
  42. Praschak-Rieder N, Kennedy J, Wilson AA, Hussey D, Boovariwala A, Willeit M, Ginovart N, Tharmalingam S, Masellis M, Houle S, Meyer JH: Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study. Biol Psychiatry 2007;62:327-331.
    External Resources
  43. Mortensen OV, Thomassen M, Larsen MB, Whittemore SR, Wiborg O: Functional analysis of a novel human serotonin transporter gene promoter in immortalized raphe cells. Brain Res Mol Brain Res 1999;68:141-148.
    External Resources
  44. Carrol ED, Salway F, Pepper SD, Saunders E, Mankhambo LA, Ollier WE, Hart CA, Day P: Successful downstream application of the Paxgene Blood RNA system from small blood samples in paediatric patients for quantitative PCR analysis. BMC Immunol 2007;8:20.
    External Resources
  45. Hu N, Tan MS, Yu JT, Sun L, Tan L, Wang YL, Jiang T, Tan L: Increased expression of TREM2 in peripheral blood of Alzheimer's disease patients. J Alzheimers Dis 2014;38:497-501.
    External Resources
  46. Watanabe S, Iga J, Nishi A, Numata S, Kinoshita M, Kikuchi K, Nakataki M, Ohmori T: Microarray analysis of global gene expression in leukocytes following lithium treatment. Hum Psychopharmacol Clin Exp 2014;29:190-198.
    External Resources
  47. Watanabe SY, Iga J, Ishii K, Numata S, Shimodera S, Fujita H, Ohmori T: Biological tests for major depressive disorder that involve leukocyte gene expression assays. J Psychiatr Res 2015;66-67:1-6.
    External Resources
  48. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-408.
    External Resources
  49. Kanda Y: Investigation of the freely available easy-to-use software ‘EZR' for medical statistics. Bone Marrow Transplant 2013;48:452-458.
    External Resources
  50. Bradley SL, Dodelzon K, Sandhu HK, Philibert RA: Relationship of serotonin transporter gene polymorphisms and haplotypes to mRNA transcription. Am J Med Genet B Neuropsychiatr Genet 2005;136B:58-61.
    External Resources
  51. Talati A, Guffanti G, Odgerel Z, Ionita-Laza I, Malm H, Sourander A, Brown AS, Wickramaratne PJ, Gingrich JA, Weissman MM: Genetic variants within the serotonin transporter associated with familial risk for major depression. Psychiatry Res 2015;228:170-173.
    External Resources
  52. Kunugi H, Ueki A, Otsuka M, Isse K, Hirasawa H, Kato N, Nabika T, Kobayashi S, Nanko S: Alzheimer's disease and 5-HTTLPR polymorphism of the serotonin transporter gene: no evidence for an association. Am J Med Genet 2000;96:307-309.
    External Resources
  53. Tsai SJ, Hong CJ, Liu TY, Cheng CY, Liu HC: Association study for a functional serotonin transporter gene polymorphism and late-onset Alzheimer's disease for Chinese patients. Neuropsychobiology 2001;44:27-30.
    External Resources
  54. Fehér A, Juhász A, László A, Pákáski M, Kálmán J, Janka Z: Serotonin transporter and serotonin receptor 2A gene polymorphisms in Alzheimer's disease. Neurosci Lett 2013;534:233-236.
    External Resources
  55. Lorenzi C, Marcone A, Pirovano A, Marino E, Cordici F, Cerami C, Delmonte D, Cappa SF, Bramanti P, Smeraldi E: Serotonin transporter and saitohin genes in risk of Alzheimer's disease and frontotemporal lobar dementia: preliminary findings. Neurol Sci 2010;31:741-749.
    External Resources
  56. Seripa D, Franceschi M, D'Onofrio G, Panza F, Cascavilla L, Paris F, Placentino G, Matera MG, Solfrizzi V, Pilotto A: Polymorphism C in the serotonin transporter gene (SLC6A4) in questionable dementia and Alzheimer's disease. Neurosci Lett 2008;438:335-339.
    External Resources
  57. Nishimura AL, Guindalini C, Oliveira JR, Nitrini R, Bahia VS, de Brito-Marques PR, Otto PA, Zatz M: Monoamine oxidase a polymorphism in Brazilian patients: risk factor for late-onset Alzheimer's disease? J Mol Neurosci 2005;27:213-217.
    External Resources
  58. Zill P, Padberg F, de Jonge S, Hampel H, Bürger K, Stübner S, Boetsch T, Jürgen Möller H, Ackenheil M, Bondy B: Serotonin transporter (5-HTT) gene polymorphism in psychogeriatric patients. Neurosci Lett 2000;284:113-115.
    External Resources
  59. Oliveira JR, Gallindo RM, Maia LG, Brito-Marques PR, Otto PA, Passos-Bueno MR, Morais MA Jr, Zatz M: The short variant of the polymorphism within the promoter region of the serotonin transporter gene is a risk factor for late onset Alzheimer's disease. Mol Psychiatry 1998;3:438-441.
    External Resources
  60. Porcelli S, Fabbri C, Serretti A: Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy. Eur Neuropsychopharmacol 2012;22:239-258.
    External Resources
  61. Watanabe SY, Iga J, Ishii K, Numata S, Shimodera S, Fujita H, Ohmori T: Biological tests for major depressive disorder that involve leukocyte gene expression assays. J Psychiatr Res 2015;66-67:1-6.
    External Resources
  62. Martin J, Cleak J, Willis-Owen SAG, Flint J, Shifman S: Mapping regulatory variants for the serotonin transporter gene based on allelic expression imbalance. Mol Psychiatry 2007;12:421-422.
    External Resources
  63. Murthy NV, Selvaraj S, Cowen PJ, Bhagwagar Z, Riedel WJ, Peers P, Kennedy JL, Sahakian BJ, Laruelle MA, Rabiner EA, Grasby PM: Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [11C] DASB binding in the living human brain. Neuroimage 2010;52:50-54.
    External Resources
  64. Gao Z, Yuan H, Sun M, Wang Z, He Y, Liu D: The association of serotonin transporter gene polymorphism and geriatric depression: a meta-analysis. Neurosci Lett 2014;578:148-152.
    External Resources
  65. Smits KM, Smits LJ, Schouten JS, Stelma FF, Nelemans P, Prins MH: Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review. Mol Psychiatry 2004;9:433-441.
    External Resources
  66. Goldman N, Glei DA, Lin, YH, Weinstein M: The serotonin transporter polymorphism (5-HTTLPR): allelic variation and links with depressive symptoms. Depress Anxiety 2010;27:260-269.
    External Resources
  67. Murphy DL, Moya PR: Human serotonin transporter gene (SLC6A4) variants: their contributions to understanding pharmacogenomic and other functional GxG and GxE differences in health and disease. Curr Opin Pharmacol 2011;11:3-10.
    External Resources
  68. Kim JM, Stewart R, Kang HJ, Kim SW, Shin IS, Kim HR, Shin MG, Kim JT, Park MS, Cho KH, Yoon JS: A longitudinal study of SLC6A4 DNA promoter methylation and poststroke depression. J Psychiatr Res 2013;47:1222-1227.
    External Resources
  69. Domschke K, Tidow N, Schwarte K, Deckert J, Lesch KP, Arolt V, Zwanzger P, Baune BT: Serotonin transporter gene hypomethylation predicts impaired antidepressant treatment response. Int J Neuropsychopharmacol 2014;17:1167-1176.
    External Resources
  70. Devlin AM, Brain U, Austin J, Oberlander TF: Prenatal exposure to maternal depressed mood and the MTHFR C677T variant affect SLC6A4 methylation in infants at birth. PLoS One 2010;5:e12201.
    External Resources
  71. Alasaari JS, Lagus M, Ollila HM, Toivola A, Kivimäki M, Vahtera J, Kronholm E, Härmä M, Puttonen S, Paunio T: Environmental stress affects DNA methylation of a CpG rich promoter region of serotonin transporter gene in a nurse cohort. PLoS One 2012;7:e45813.
    External Resources
  72. Kang HJ, Kim JM, Stewart R, Kim SY, Bae KY, Kim SW, Shin IS, Shin MG, Yoon JS: Association of SLC6A4 methylation with early adversity, characteristics and outcomes in depression. Prog Neuropsychopharmacol Biol Psychiatry 2013;44:23-28.
    External Resources
  73. Okada S, Morinobu S, Fuchikami M, Segawa M, Yokomaku K, Kataoka T, Okamoto Y, Yamawaki S, Inoue T, Kusumi I, Koyama T, Tsuchiyama K, Terao T, Kokubo Y, Mimura M: The potential of SLC6A4 gene methylation analysis for the diagnosis and treatment of major depression. J Psychiatr Res 2014;53:47-53.
    External Resources
  74. Philibert RA, Sandhu H, Hollenbeck N, Gunter T, Adams W, Madan A: The relationship of 5HTT (SLC6A4) methylation and genotype on mRNA expression and liability to major depression and alcohol dependence in subjects from the Iowa Adoption Studies. Am J Med Genet B Neuropsychiatr Genet 2008;147B:543-549.
    External Resources
  75. Belzeaux R, Azorin JM, Ibrahim EC: Monitoring candidate gene expression variations before, during and after a first major depressive episode in a 51-year-old man. BMC Psychiatry 2014;14:73.
    External Resources
  76. Mori T, Shimada H, Shinotoh H, Hirano S, Eguchi Y, Yamada M, Fukuhara R, Tanimukai S, Zhang MR, Kuwabara S, Ueno S, Suhara T: Apathy correlates with prefrontal amyloid β deposition in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2013;85:449-455.
    External Resources

Article / Publication Details

First-Page Preview
Abstract of Original Research Article

Accepted: June 01, 2016
Published online: July 15, 2016
Issue release date: August 2016

Number of Print Pages: 14
Number of Figures: 6
Number of Tables: 4

ISSN: 1420-8008 (Print)
eISSN: 1421-9824 (Online)

For additional information: https://www.karger.com/DEM

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Article Tools
Article Details

2016, Vol.41, No. 5-6

August 2016

Free Supplementary Material

Article

Recommend This
TOP